“Johnson & Johnson’s experimental coronavirus vaccine protected macaque monkeys with a single shot in a pre-clinical study, potentially gaining on other vaccines that are further along in testing but require two doses over time,” reports Bloomberg:
Five of six primates exposed to the pandemic-causing pathogen were immune after a single injection. The exception showed low levels of the virus, according to a…
Tag: GlaxoSmithKline PLC
23andMe Licenses Antibody It Developed From its Genetic Database To Spanish Firm Almirall
23andMe has licensed an antibody it developed from its genetic database to treat inflammatory diseases to Spanish drugmaker Almirall SA. “The deal, announced by Almirall in a filing with Spanish regulators on Thursday, marks the first time that 23andMe has licensed a drug compound that it has developed itself,” reports Bloomberg. From the report: Leveraging its genetic data to develop drugs…
Global Health: Widespread Testing Begins on Malaria Vaccine That Is Only Partly Effective
Despite the vaccine’s drawbacks, the W.H.O. endorsed testing on 360,000 children, in an effort to lower death rates in Africa. Source: https://www.nytimes.com/2019/04/24/health/malaria-vaccine-malawi.html?partner=rss&emc=rss…